Search Results - "Chiradoni Thungappa, S."

128P Precision genomics based targeted 12 gene biomarker and PD-L1 testing in advanced non-small cell lung cancer patients as an alternative to conventional EGFR, ALK, ROS-1 sequential testing in a tertiary care hospital by Nagaraj, M., Patil, S., Thippeswamy, R., Chiradoni Thungappa, S.

Get full text

246P Nanosomal paclitaxel lipid suspension demonstrates better tumor response and safety versus conventional paclitaxel in patients with metastatic breast cancer by Chiradoni Thungappa, S., Taran, R., Singh, J.K., Shrivastav, S.P., Vithalani, N.K., Mukherjee, K.K., Nagarkar, R., Maksud, T.M., Mehta, A., Srinivasan, K., Vikranth, M., Sonawane, S.R., Ahmad, A., Sheikh, S., Ali, S.M., Paithankar, M., Rajani, A., Bunger, D., Khan, M.A., Ahmad, I.

Get full text

423P Insights into clinically actionable biomarkers in an Indian cancer cohort of 1000 patients using comprehensive genomic profiling (CGP) by Ghosh, M., Balaram, G., Lingaraju, S.M., Raghavendrachar, K., Kodandapani, R., Erappareddy, V., Keriyappa, V., Ghorpade, S.N., Patil, S., Chiradoni Thungappa, S., Bhattacharjee, S., Papaiah Susheela, S., Naseer R, M., Dasgupta, R., Belagutti Jayappa, S., Ramaswamy, V., Hattangdi, D., Ravichandran, A., Bahadur, U., Ajaikumar, B.S.

Get full text

59P Comprehensive genomic profiling (CGP) unravels druggable targets in breast carcinoma (BC): A single institutional experience by Lingaraju, S.M., Raghavendrachar, K., Balaram, G., Kodandapani, R., Erappareddy, V., Keriyappa, V., Ghorpade, S.N., Patil, S., Chiradoni Thungappa, S., Papaiah Susheela, S., Belagutti Jayappa, S., Bhattacharjee, S., Naseer R, M., Dasgupta, R., Hattangdi, D., Nanjaiah, T., Ravichandran, A., Bahadur, U., Ajaikumar, B.S., Ghosh, M.

Get full text

147P Four-year overall survival (OS) update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC) by Chan, S.L., Sangro, B., Kelley, R.K., Lau, G., Kudo, M., Sukeepaisarnjaroen, W., De Toni, E.N., Furuse, J., Kang, Y-K., Galle, P.R., Rimassa, L., Heurgue, A., Tam, V.C., Dao, T.V., Chiradoni Thungappa, S., Breder, V., Ostapenko, Y.V., Reig Monzon, M.E., Gupta, C., Abou-Alfa, G.K.

Get full text

421P Comprehensive genomic profiling (CGP) unravels somatic BRCA (sBRCA) and homologous recombinant repair (HRR) gene alterations across multi-cancer spectrum by Kodandapani, R., Lingaraju, S.M., Raghavendrachar, K., Balaram, G., Erappareddy, V., Keriyappa, V., Ghorpade, S.N., Patil, S., Chiradoni Thungappa, S., Papaiah Sheela, S., Belagutti Jayappa, S., Bhattacharjee, S., Dasgupta, R., Naseer R, M., Hattangdi, D., Ravichandran, A., Bahadur, U., Ajaikumar, B.S., Ghosh, M.

Get full text

530P Ultra low bevacizumab (BEVULTRA-100) as a novel approach in symptomatic management of high grade glioma: Can minimal dose make a difference? by Anuradha, P., Susheela, S. Papaiah, Damodara, P., Hegde, S., Suresh, S., Ghosh, R., Gopireddy, S.S., Krishnappa, R., Naik, R., Jayappa, S. Belagutti, Gupta, V., Thungappa, S. Chiradoni, Revannasiddaiah, S., Hamid, M., Gopal, S., Rudrappa, S., HV, M., NK, V., Kallur, K., Patil, S.

Get full text

136P Circadian rhythm positioned chronomodulated-SBRT with cancer associated fibroblast elimination theranostic treatment to harmonize resistant TFG-Beta stromal microenvironment in conjunction with PDL-1 based immunotherapy in disseminated cancers-concept randomised study by Lohith, G., Sekar, K., Kallur, K., Bj, S., Chiradoni Thungappa, S., Thippeswamy, R., Naseer R, M., Swamy, S., Patil, S., Bs, A.

Get full text